Weekly Digest – December 2024 Weekly Digest – December 2024 26 Dec 2024: IND application for a phase I/II clinical study of anti-HER2 bispecific ADC subcutaneous co-formulation JSKN033 was approved Alphamab Oncology has received approval from the CDE of the […]